The Business Research Company’s Cervical Cancer Diagnostics Global Market Report 2021 – COVID-19 Growth And Change
LONDON, GREATER LONDON, UK, September 21, 2021 /EINPresswire.com/ — The rising adoption of cervical cancer diagnostic tests for the early detection of cervical cancer is expected to drive the market for cervical cancer diagnostics. Increasing awareness among women about cervical cancer along with the emphasis by worldwide cancer organizations and governments on early testing for detecting cervical cancer and preventing it contributes to the growth of the market. For instance, in August 2018, the United States Preventive Services Task Force has updated its screening guidelines for cervical cancer, which specifies that women between ages 21 to 29 should be screened with a Pap test every 3 years, women between ages 30 to 65 should be screened with any of three tests, namely high-risk HPV testing alone, Pap and high-risk HPV contesting for every 5 years and Pap test alone for every 3 years. The rising adoption of cervical cancer diagnostic tests and emphasis on early diagnosis propels the market.
The global cervical cancer diagnostics market size is expected to grow from $7.23 billion in 2020 to $7.66 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The cervical cancer screening market is expected to reach $9.69 billion in 2025 at a CAGR of 6%.
Read More On The Global Cervical Cancer Diagnostics Market Report:
Major players covered in the global cervical cancer diagnostics industry are Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens Healthineers AG, Zilico, Guided Therapeutics.
TBRC’s global cervical cancer diagnostics tests market analysis report is segmented by diagnostic test into pap smear test, HPV test, colposcopy, biopsy and endocervical curettage, other diagnostic tests, by end user into hospitals, specialty clinics, cancer and radiation therapy centers, diagnostic centers, by age group into below 21, between 21 to 29, between 30 to 65, above 65.
Cervical Cancer Diagnostics Global Market Report 2021 – By Diagnostic Test (Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage), By End User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers, Diagnostic Centers), By Age Group (Below 21, Between 21 To 29, Between 30 To 65, Above 65), COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provides cervical cancer diagnostics market overview, forecast cervical cancer diagnostics market size and growth for the whole market, cervical cancer diagnostics market segments, and geographies, cervical cancer diagnostics market trends, cervical cancer diagnostics market drivers, cervical cancer diagnostics market restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Cervical Cancer Diagnostics Market Report:
Here Is A List Of Similar Reports By The Business Research Company:
Cancer Diagnostics Global Market Report 2021 – By Products (Companion Diagnostics, Molecular Diagnostics), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma), COVID-19 Growth And Change
Transplant Diagnostics Global Market Report 2021 – By Type (Reagent & Consumables, Instrument, Software & Services), By Transplant Type (Solid Organ, Stem Cell), By End User (Hospitals And Transplant Centers, Research Laboratories & Transplant Centers, Commercial Service Providers), By Technology (Non-Molecular Assay, Molecular Assay), By Organ (Kidney, Liver, Heart, Lung, Pancreas), COVID-19 Growth And Change
Breast Cancer Diagnostics Global Market Report 2021 – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC)), By Cancer Type (BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer), By Diagnostic Type (Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies), By End Users (Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers), COVID-19 Impact And Recovery
Interested to know more about The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Or get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Source: EIN Presswire